Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function
NCT04043520Phase 4Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Sep 2019
- Primary completion
- Aug 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of degarelix in abdominal obesity, sponsored by University of Colorado Denver. Started Sep 2019; status: recruiting.
02
Drugs
degarelix
03
Conditions
abdominal obesity
Beyond the preview
Go deeper on NCT04043520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043520.